Mymetics Corp (MYMX)

[Work Harder]

Preclinical profiling of the immunogenicity of a two-component subunit malaria vaccine candidate based on virosome technology

https://www.researchgate.net/publication/215637434_Preclinical_profiling_of_the_immunogenicity_of_a_two-component_subunit_malaria_vaccine_candidate_based_on_virosome_technology

Shinji Okitsu

Rinaldo Zurbriggen

Mario Amacker

Gerd Pluschke

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=142655080

Shinji Okitsu

2 Swiss Tropical and Public Health Institute, Basel, Switzerland

Oh Yeow, Swills Topical

LOL